GTBPVSUROY• 12 Months (Normalized)
GTBP vs UROY (GT Biopharma Inc. vs Uranium Royalty Corp.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+854.62%
GT Biopharma Inc.
Normalized Baseline0.00%
UROY Performance $3.97
-5.48%
Uranium Royalty Corp.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+860.1 pts
GTBP outperforming by 860.10 percentage points
GTBPUROY
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP UROY
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(250 dates)
| Date | GTBP Price | GTBP Gain (%) | UROY Price | UROY Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +854.62% | $3.97 | -5.48% | +860.10% |
| Sep 29, 2026 | $6.88 | +975.90% | $- | - | |
| Sep 28, 2026 | $6.80 | +964.16% | $4.00 | -4.76% | +968.92% |
| Sep 25, 2026 | $6.89 | +978.25% | $4.14 | -1.43% | +979.68% |
| Sep 24, 2026 | $6.83 | +968.86% | $4.25 | +1.19% | +967.67% |
| Sep 23, 2026 | $7.10 | +1011.11% | $4.42 | +5.24% | +1005.87% |
| Sep 22, 2026 | $- | $4.51 | +7.38% | - | |
| Sep 21, 2026 | $7.18 | +1023.63% | $4.24 | +0.95% | +1022.68% |
| Sep 18, 2026 | $7.16 | +1020.50% | $4.56 | +8.57% | +1011.93% |
| Sep 17, 2026 | $7.49 | +1072.14% | $4.48 | +6.67% | +1065.47% |
| Sep 16, 2026 | $7.81 | +1122.22% | $4.39 | +4.52% | +1117.70% |
| Sep 15, 2026 | $9.00 | +1308.45% | $4.28 | +1.90% | +1306.55% |
| Sep 14, 2026 | $11.63 | +1720.03% | $4.24 | +0.95% | +1719.08% |
| Sep 11, 2026 | $8.61 | +1247.42% | $4.36 | +3.69% | +1243.73% |
| Sep 10, 2026 | $6.18 | +867.14% | $4.50 | +7.14% | +860.00% |
Page 1 of 17